BioMarin Pharmaceuticals
BMRN
BMRN
429 hedge funds and large institutions have $14.6B invested in BioMarin Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 147 increasing their positions, 158 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
429
Holders Change
-9
Holders Change %
-2.05%
% of All Funds
9.85%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.21%
New
48
Increased
147
Reduced
158
Closed
53
Calls
$76.6M
Puts
$97.9M
Net Calls
-$21.4M
Net Calls Change
-$74.2M
Top Buyers
Top Sellers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$148M |
2 |
Citadel Advisors
Miami,
Florida
|
-$76.2M |
3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$57.8M |
4 |
![]()
JPMorgan Chase & Co
New York
|
-$42.8M |
5 |
MWNA
Marshall Wace North America
New York
|
-$39M |